NPPA Fixes Retail Price of 51 Formulations, Details Dr. Divya Colin18 Sep 2023 12:30 PM GMTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers,...
Linagliptin The Evergreen Gliptin: Indian Position Paper Highlights Wide Clinical Applicabilities of Linagliptin in T2DM Dr. Kamal Kant Kohli14 Sep 2023 6:15 AM GMTA recent position paper from India has reported that Linagliptin is clinically beneficial across a wide range of patients eliminating the need for...
USV Launches Liralin Range for Diverse Group of Type 2 Diabetes Patients MD BRAND CONNECT4 Sep 2023 8:25 AM GMTUSV Pvt. Ltd, a leading drug manufacturer in the diabetes & cardiology segment, has announced the launch of the Liralin Range for the treatment...
Lupin buys diabetes brands Ondero, Ondero Met from Boehringer Ingelheim International for Rs 235 Crore Ruchika Sharma19 Aug 2023 8:57 AM GMTMumbai: Global pharma major Lupin Limited has announced the acquisition of diabetes brands ONDERO and ONDERO MET, from Boehringer Ingelheim...
Micro Labs Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Drug Dr. Divya Colin10 Jun 2023 12:15 PM GMTNew Delhi: Micro Lab has got the green signal from the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization...
Alkem Gets CDSCO Panel Nod To Manufacture, Market Linagliptin, Dapagliflozin antidiabetic FDC Dr. Divya Colin2 Jun 2023 12:30 PM GMTNew Delhi: The drug major Alkem Health Sciences has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug...
Empagliflozin tied to meaningful reduction of HbA1c compared to linagliptin in young diabetes patients: Lancet Jacinthlyn Sylvia9 March 2023 5:45 AM GMTA new study published in The Lancet Diabetes & Endocrinology suggests that linagliptin did not reduce HbA1c in a clinically meaningful way,...
SGLT2 inhibitor empagliflozin could be new treatment option for children with type 2 diabetes: Lancet Dr. Kamal Kant Kohli4 March 2023 5:30 AM GMTUSA: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, findings from a phase 3 clinical trial have...
Torrent Pharma collaborates with Boehringer Ingelheim India to co-market its anti-diabetic drug, its fixed dose combinations in India Ruchika Sharma14 Dec 2022 11:20 AM GMTAhmedabad: Torrent Pharmaceuticals Ltd has entered into a strategic alliance with Boehringer Ingelheim India Private Limited to co-market Cospiaq...
Combinations of 45 medicines fixed, including Sitagliptin- Metformin, Linagliptin -Metformin combinations Roshni Dhar27 Aug 2022 12:50 PM GMTThrough a recent notice, The National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India has fixed...
Health Bulletin 27/August/2022 Roshni Dhar27 Aug 2022 12:02 PM GMTHere are the top health news for the day:'Inhumane Torture' and ragging horror at SVN medical college, junior residents made to stand continuously,...
Combinations of 45 medicines fixed, including Sitagliptin- Metformin, Linagliptin -Metformin combinations Ruchika Sharma25 Aug 2022 11:30 AM GMTNew Delhi: Through a recent notice, The National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
